LifeStance Health (LFST) Debt to Equity (2021 - 2025)
LifeStance Health (LFST) has disclosed Debt to Equity for 5 consecutive years, with $0.17 as the latest value for Q4 2025.
- On a quarterly basis, Debt to Equity fell 9.62% to $0.17 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.17, a 9.62% decrease, with the full-year FY2025 number at $0.17, down 9.62% from a year prior.
- Debt to Equity was $0.17 for Q4 2025 at LifeStance Health, down from $0.18 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.2 in Q4 2023 to a low of $0.11 in Q2 2021.
- A 5-year average of $0.16 and a median of $0.17 in 2025 define the central range for Debt to Equity.
- Peak YoY movement for Debt to Equity: soared 42.9% in 2022, then decreased 9.62% in 2025.
- LifeStance Health's Debt to Equity stood at $0.11 in 2021, then skyrocketed by 42.9% to $0.16 in 2022, then grew by 27.24% to $0.2 in 2023, then dropped by 4.17% to $0.19 in 2024, then decreased by 9.62% to $0.17 in 2025.
- Per Business Quant, the three most recent readings for LFST's Debt to Equity are $0.17 (Q4 2025), $0.18 (Q3 2025), and $0.19 (Q2 2025).